AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Zubogesic Sublingual tablet

Prescription Icon
Prescription Required

Marketer

Fibovil Pharmaceuticals Pvt Ltd

Salt Composition

Piroxicam (20mg)

Overview Zubogesic Sublingual tablet

LinguaGesic sublingual tablets offer pain relief for moderate to severe discomfort. Indicated for conditions like osteoarthritis and rheumatoid arthritis, it targets joint and muscle pain and inflammation. Post-dental surgery pain management is another potential application. Administer LinguaGesic with food to minimize gastrointestinal upset. Dosage and treatment length are determined by your specific needs and response. Strict adherence to the prescribed regimen is crucial for optimal results; exceeding the recommended dose or duration poses risks. Common side effects include mild nausea, vomiting, indigestion, stomach pain, and diarrhea. Report any persistent or worsening side effects to your physician, who can offer management strategies. Prior to use, disclose any history of stomach ulcers, cardiovascular disease, hypertension, or liver/kidney impairment to your doctor. Similarly, inform your doctor of all other medications you're currently using due to potential interactions. Pregnant or breastfeeding individuals should seek medical advice before using LinguaGesic.

Primary Ingredients of Zubogesic Sublingual tablet

No information provided. Please provide the text you wish me to rephrase.

Uses of Zubogesic Sublingual tablet

Analgesia

Major Benefits of Zubogesic Sublingual tablet:

Dissolve the Zubogesic Sublingual tablet under your tongue or against the inner cheek. Avoid chewing, crushing, or swallowing the medication whole. Administer this medication with a meal.

Common Side effects of Zubogesic Sublingual tablet:

  • Vomiting
  • Stomach pain
  • Nausea
  • Headache
  • Dizziness

How to use Zubogesic Sublingual tablet:

Dissolve the Zubogesic Sublingual tablet by placing it either under your tongue or against your gum. Avoid chewing, crushing, or swallowing the tablet whole. This medication should be taken with food.

How Zubogesic Sublingual tablet works:

Lingual Zubogesic tablets function as a non-steroidal anti-inflammatory drug (NSAID), inhibiting the production of inflammatory mediators responsible for pain and edema.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent use of alcohol and Zubogesic Sublingual tablets is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Zubogesic Sublingual tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against potential hazards prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Zubogesic Sublingual tablets while breastfeeding is likely inadvisable. Preliminary human evidence indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingUNSAFE

Taking a Zubogesic Sublingual tablet could reduce alertness, impair vision, and cause drowsiness or dizziness. Driving should be avoided if any of these effects are experienced.

KidneyKidneyCAUTION

For individuals with significant kidney impairment, the use of Zubogesic Sublingual tablets requires careful monitoring. Dosage modification of Zubogesic Sublingual tablets may be necessary. Physician consultation is advised.

LiverLiverCAUTION

Patients with liver impairment should exercise caution when using Zubogesic Sublingual tablets. Dosage modification may be necessary; physician consultation is advised.

What if you forget to take Zubogesic Sublingual tablet :

Should you forget a Zubogesic Sublingual tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed one and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Zubogesic Sublingual tablet

LabelValue
Chemical Type Enolic Acid Esters and Related Compounds
Developing Habits No.
Type of Therapy Pain Relievers

FAQs on Zubogesic Sublingual tablet

Zubogesic Sublingual tablets and diclofenac are both analgesics. Diclofenac, however, exhibits greater selectivity for the COX-2 enzyme than piroxicam, a non-selective COX inhibitor. This increased selectivity potentially reduces side effects compared to Zubogesic Sublingual tablets.
Zubogesic Sublingual tablets and naproxen are equally effective non-selective COX inhibitor pain relievers; however, naproxen has fewer reported gastric side effects.
Meloxicam and Zubogesic Sublingual tablets are equally effective non-selective COX inhibitors used for pain relief. However, meloxicam exhibits fewer acute gastric side effects than Zubogesic Sublingual tablets.
Ketoprofen and Zubogesic Sublingual tablets are both non-selective COX inhibitor pain relievers. However, research indicates that topical ketoprofen gel offers superior efficacy and tolerability compared to Zubogesic Sublingual tablets.
Zubogesic Sublingual tablets target inflammation and pain by inhibiting COX enzymes, unlike Tramadol, a habit-forming, narcotic-like painkiller.
Zubogesic Sublingual tablets and nimesulide are both analgesics. Unlike nimesulide, which selectively inhibits COX-2, Zubogesic Sublingual tablets non-selectively inhibit COX enzymes. This selectivity makes nimesulide potentially less prone to side effects than piroxicam. Nimesulide is not suitable for children under 12.
Chikungunya typically doesn't lower platelet counts, but painkillers such as piroxicam increase bleeding risk. Therefore, avoid Zubogesic Sublingual or any painkillers for fever with joint pain. Always consult your doctor before using Zubogesic Sublingual.
Zubogesic Sublingual tablets and aspirin are distinct medications, although both are COX (cyclooxygenase) inhibitors with anti-inflammatory and analgesic properties.
Concurrent use of Zubogesic Sublingual tablets and dexamethasone is contraindicated due to their synergistic toxicity, significantly increasing the risk of gastrointestinal ulceration.
Yes, methocarbamol and Zubogesic Sublingual tablets may be used together; however, always inform your doctor before starting either medication.
While no significant adverse interactions are known between paracetamol and Zubogesic Sublingual tablets, it's advisable to consult your doctor before using them together.
Zubogesic Sublingual tablets are a non-steroidal anti-inflammatory drug (NSAID).
Zubogesic Sublingual tablets contain sulfur and may cause serious adverse reactions, including severe skin conditions like Stevens-Johnson syndrome, in susceptible individuals. Report any allergies to your doctor.
Zubogesic Sublingual tablets are analgesics, not anticoagulants. Their use is contraindicated in patients with bleeding disorders.
Zubogesic Sublingual tablets are not muscle relaxants; they're analgesics that inhibit COX enzymes, reducing inflammation and pain.
Zubogesic Sublingual tablets are not narcotics. They're analgesics that reduce pain and inflammation by inhibiting COX enzymes, which are responsible for producing these sensations.
Zubogesic Sublingual tablets do not treat hypertension. Concurrent use with antihypertensive medications reduces their effectiveness. Tell your doctor if you take antihypertensive medications before using Zubogesic Sublingual tablets.
Don't take Zubogesic Sublingual tablets with Losartan. Zubogesic Sublingual tablets reduce the effectiveness of Losartan and other antihypertensive medications, potentially causing your blood pressure treatment to fail. Tell your doctor about all antihypertensive medications you're taking before starting Zubogesic Sublingual tablets.
Don't take Zubogesic Sublingual tablets with lisinopril. Piroxicam, a component of Zubogesic, reduces lisinopril's effectiveness, potentially causing hypertension treatment failure. Tell your doctor about all antihypertensive medications you're taking before using Zubogesic Sublingual tablets.
Yes, Zubogesic Sublingual tablets can be taken with calcium channel blockers. Unlike other antihypertensive drugs, calcium channel blockers' efficacy isn't diminished by NSAIDs (White, 2007).
Zubogesic Sublingual tablets can be used with tizanidine. Piroxicam, a pain reliever, and tizanidine, a muscle relaxant, are often used together for conditions such as back pain.
Zubogesic Sublingual tablets are compatible with beta-cyclodextrin. Studies indicate this combination accelerates piroxicam's onset and mitigates gastrointestinal adverse effects.
Yes, alternatives to Zubogesic Sublingual tablets exist. Pain medication is tailored to individual needs. Discuss any changes to your piroxicam treatment with your doctor.
Piroxicam is contraindicated in patients with allergies, bleeding disorders, duodenal, gastric, or peptic ulcers, stomatitis, systemic lupus erythematosus (SLE), ulcerative colitis, upper gastrointestinal disease, late pregnancy, cardiac or hepatic impairment, and renal dysfunction.
Zubogesic Sublingual tablets are not for treating allergies; they are an analgesic.
Zubogesic Sublingual tablets provide long-lasting pain relief. While a single daily dose often suffices, individual responses vary, and piroxicam's effectiveness generally improves with several weeks of use.
Zubogesic Sublingual tablets are a non-narcotic pain reliever and are not associated with causing high blood pressure.
Menstrual cramps are not an approved indication for Zubogesic Sublingual tablets. However, studies demonstrate piroxicam's significant effectiveness in relieving menstrual cramps.
While not approved for migraine treatment, studies show Zubogesic Sublingual tablets effectively reduce migraine pain (without aura).
Yes, it may help reduce back pain. However, proper diagnosis from your doctor is crucial before starting any treatment. Do not self-treat with Zubogesic Sublingual tablets; back pain causes vary widely.
Yes, Zubogesic Sublingual tablets are a proven effective treatment for acute gout, supported by research.
Blood donation is permissible while taking Zubogesic Sublingual tablets, but please inform your doctor beforehand.
In diabetic patients, Zubogesic Sublingual tablets should only be used under a doctor's supervision. Prolonged use of this medication, containing piroxicam, can significantly increase the risk of renal failure, a risk already heightened by diabetes itself.
Zubogesic Sublingual tablets are contraindicated in individuals with impaired renal function due to the risk of renal papillary necrosis and other kidney injuries associated with long-term NSAID use.
Zubogesic Sublingual tablets can cause serious skin reactions, including potentially fatal exfoliative dermatitis, Stevens-Johnson syndrome (SJS), and toxic epidermal necrolysis (TEN). These severe reactions may develop unexpectedly. Stop taking the medication and consult your doctor immediately if you experience even a mild rash.
Zubogesic Sublingual tablets are contraindicated during pregnancy. Their use risks premature ductus arteriosus closure, potentially causing fetal heart failure and death.
Zubogesic Sublingual tablets are contraindicated for patients with active peptic ulcers due to the drug's potential to cause gastric ulceration and bleeding.
Aspirin and other NSAIDs can trigger severe asthma attacks in some susceptible individuals. Always consult your doctor before taking NSAIDs if you have asthma.
Zubogesic Sublingual tablets may cause temporary infertility in some cases, as piroxicam's mechanism can interfere with ovarian follicle rupture. This effect is usually reversible. Consult your physician before use.
Zubogesic Sublingual tablets and diuretics shouldn't be used together. In some patients, Zubogesic Sublingual tablets counteract the sodium-excreting effects of furosemide and thiazides, likely due to suppressed renal prostaglandin production.
Avoid using Zubogesic Sublingual tablets with lithium. These tablets raise plasma lithium levels and decrease renal lithium clearance by inhibiting renal prostaglandin synthesis. Always inform your doctor before taking Zubogesic Sublingual tablets if you are also taking lithium.
Concurrent use of Zubogesic Sublingual tablets and warfarin is contraindicated due to increased bleeding risk. Disclose warfarin use to your physician before taking Zubogesic. If both medications are used, close monitoring is essential.
Taking corticosteroids and anticoagulants raises the risk of gastric ulcers. Other factors increasing this risk include long-term use of such medications, alcohol consumption, smoking, and advanced age.
Patients experiencing asthma attacks, hives, or other allergic reactions to aspirin or other NSAIDs, either before or after cardiac bypass surgery.
Gastrointestinal upset, and in rare instances, severe gastrointestinal complications including ulcers and bleeding; serious skin reactions like exfoliative dermatitis, Stevens-Johnson syndrome (SJS), and toxic epidermal necrolysis; liver failure; and kidney damage.
Zubogesic Sublingual tabl...
108
MRP 125
13% off